Transposon Therapeutics, Inc. is pioneering novel therapies targeting LINE-1 activity, including reverse transcriptase and other key mediators of LINE-1-induced pathology, with a focus on treating neurodegenerative diseases.
Company Details
- Employees
- 11
- Founded
- -
- Address
- 4660 La Jolla Village Dr,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.transposonrx.com
- Keywords
- Neurology and LINE-1.
- HQ
- San Diego, California
Transposon Therapeutics, Inc. Questions
Transposon Therapeutics, Inc.'s website is http://www.transposonrx.com
Transposon Therapeutics, Inc.'s LinkedIn profile is https://www.linkedin.com/company/transposontherapeutics
Transposon Therapeutics, Inc. has
11 employees.
View email and phone details for 11
employees at Transposon Therapeutics, Inc..
Transposon Therapeutics, Inc.'s industry is
Biotechnology Research
Transposon Therapeutics, Inc.'s top competitors are
Pll Therapeutics,
Kadimastem Ltd.,
Modality.ai,
Amylyx Pharmaceuticals,
Neurizon,
Mitochon Pharmaceuticals, Inc.,
Eikonizo Therapeutics,
Leal Therapeutics,
Relay Therapeutics,
Genprex, Inc..
Transposon Therapeutics, Inc.'s categories are Biotechnology Research
Transposon Therapeutics, Inc.'s founding year is 2020
